Stock Market Today, Sept. 4: Planet Labs Dips 1% Despite Earnings Beat, Full-Year Guidance Raise

Planet Labs shares fell 1.28% to $18.11 despite an excellent Q2, with sales up 58% and adjusted EPS of $0.02 beating expectations. The stock softened on guidance—Q3 sales of $101M to $105M missed the $114M consensus—and on backlog growth of only 11% YoY. While some analysts updated price targets in a mixed way, the near-term revenue outlook and slower backlog growth appear to have offset the earnings beat.

Analysis

Planet Labs is a classic “good quarter, weaker visibility” setup: the market is likely to tolerate headline beats for a few sessions, but a premium software-like multiple is hard to defend if bookings/backlog are not compounding at the same pace as revenue. At ~17x sales, the stock is pricing a cleaner transition from imagery vendor to recurring analytics platform; slower backlog growth suggests that transition is not yet showing up in forward demand quality.

Near term, the risk is not operational collapse but multiple compression as analysts cut outer-year estimates and shift the debate from AI optionality to contract conversion. That dynamic usually takes 1-3 months to play out after earnings, especially in niche small-cap names with elevated float turnover; the current volume spike says positioning has reset, not that fundamentals have.

Second-order, the relative-value trade is within the space: if investors decide PL is too expensive for the growth visibility it offers, capital can rotate to cheaper peers with more explicit government or defense linkage, but that rotation only works if those names prove their own backlog stability. The contrarian case is that the market may already be looking through the weaker guide because the company still has a plausible path to software-like margins via historical data monetization; that thesis only matters if future bookings and gross margin inflect, not if AI remains a marketing layer. Falsifiers are simple: backlog growth reaccelerating into the mid-teens, a raised FY guide on the next print, or evidence that AI products are lifting ARPU/cross-sell rather than just narrative.

Key Decisions for Investors

• Short PL on any post-earnings bounce over the next 1-3 weeks; target a 10-15% downside move over 1-3 months if sell-side models reset to the lower Q3 run-rate. Invalidate if backlog growth or guide trends back to mid-teens+.
• For a cleaner expression, use a PL put spread dated 1-2 months out rather than outright stock: downside is tied to estimate revisions and multiple compression, while premium outlay caps risk if the market keeps looking through the guide miss.
• Relative-value watch: long BKSY / short PL only if BKSY holds sector-relative strength on days when space names trade up. This pairs lower multiple, more defense-oriented optionality against PL’s valuation risk; keep size modest because both names remain execution-sensitive.
• Do not add fresh long exposure to PL until there is evidence of backlog acceleration or better conversion metrics; if the stock re-rates down toward a lower forward-sales band after the next analyst round, reassess for a tactical entry.
• Set an alert for the next bookings/backlog update and for any commentary on AI-driven product attach rates; those are the only inputs likely to support a durable multiple expansion, and absent them the stock likely stays capped.